Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Eur J Cancer Prev. 2019 May;28(3):188–195. doi: 10.1097/CEJ.0000000000000455

Table 1.

Baseline participant characteristics

Baseline Characteristics Fish Oil (n = 70) Placebo (n = 71) P-value
Age, years, median (IQR) 57 (54, 64) 59 (55, 66) 0.37
Sex, female, n (%) 34 (48.6) 34 (47.9) 0.94
Regular aspirin or NSAID use, n (%) 47 (67.1) 37 (52.1) 0.07
Genotype, n (%)
 G/G 26 (37.1) 25 (35.2) 0.97
 G/T 25 (35.7) 26 (36.6)
 T/T 19 (27.1) 20 (28.2)
Red blood cell phospholipid fatty acids, as % of total
 Linolenic Acid, median (IQR) 11.2 (9.99, 12.6) 11.2 (9.95, 12.6) 0.89
 Arachidonic acid, median (IQR) 16.7 (14.7, 18.1) 17.2 (15.2, 18.5) 0.19
 Eicosapentaenoic acid, median (IQR) 0 (0, 0.57) 0.35 (0, 0.64) 0.29
 Docosahexaenoic acid, median (IQR) 3.48 (2.89, 4.51) 3.55 (2.82, 4.47) 0.93

P values for baseline differences determined using Wilcoxon Rank Order Sum for continuous variables and λ2 for proportions